Pascal Biosciences Inc.
Pascal Biosciences Inc. (TSXV:PAS, FSE:6PB.F) is a biopharmaceutical company founded in 2013 to advance technology licensed from the University of British Columbia. We create additional value with programs licensed from other organizations and with our in-house discovery research. Cancer is our primary focus. Strategically, we aim to leverage our innovative technologies and experienced leadership and scientific team to develop new, effective therapeutics that will change the lives of patients.
Company details
View in map
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Internationally (various countries)
- Year Founded:
- 2013
About Us
Pascal Biosciences is dedicated to improving the lives of patients suffering from life-threatening diseases including COVID-19 and intractable cancers such as glioblastoma. We are developing novel cannabinoid-based small molecules and targeted antibodies, focusing on treatments for SAR-CoV-2 infection and cancers for which there are no adequate therapies.
Team
We have assembled a team with deep scientific, clinical, business and leadership experience and expertise in biotechnology, and specifically in cancer therapeutics.